Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapySEED’s…
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL…
FORT WORTH, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial…
Lasme-cel (UCART22) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025Eti-cel (UCART20x22) Phase 1 study…
– Acquisitions strengthen profitability and competitive position with proprietary technology platform – – Missouri and Nevada transactions remain on track…
According to Pixalate’s April 2025 rankings, ‘Crossword Jam’ is No. 1 on the Apple App Store, and ‘Paper.io 2x’ is…
Select First Quarter 2025 Highlights Revenue rose 29% to $6.4 millionGross margin expanded to 46.4%Operating loss narrowed to $1.0 millionBacklog…
Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 promoter editing…
FDA Breakthrough Device Designation Awarded to AVIM Therapy FDA IDE Approved for Virtue SAB U.S. Pivotal Trial for Launch NEW…
💥 Elevate your event with Sylvie di Giusto's groundbreaking Immersive Keynote Experience, where cutting-edge 3D imaging meets actionable insights on…
This website uses cookies.
